$FUSZ: CONNECT THESE DOTS....... Salesforce (CRM:NYSE)

New Post Public Reply Private Reply Replies (0) Message Board
SHEEPWOLF
337
$FUSZ: CONNECT THESE DOTS.......

Salesforce (CRM:NYSE) recently bought Mulesoft (MULE:NYSE)
https://www.salesforce.com/company/news-press...03/180320/
WILL ORACLE JUST STAND IDLY BY?
https://en.wikipedia.org/wiki/List_of_acquisitions_by_Oracle
ORACLE (ORCL:NYSE) DID 4 ACQUISITIONS IN 2017 AND 9 IN 2016, NONE SO FAR IN 2018, IS IT TIME?

ORACLE HAS BEEN WORKING WITH nFUSZ (FUSZ:OTC) FOR MONTHS NOW TO INTEGRATE THEIR GAME CHANGING notifiCRM PRODUCT INTO ORACLE NETSUITE

LARRY ELLISON ORCL CEO LOVES NETSUITE (IT'S HIS BABY) , HE OWNS 40% OF NETSUITE
https://en.wikipedia.org/wiki/NetSuite

ORACLE NETSUITE SUITEWORLD CONFERENCE IS APRIL 23-26
http://www.netsuitesuiteworld.com/
n FUSZ CEO RORY CUTAIA RECENTLY STATED IN A CEO MONEY INTERVIEW THAT n FUSZ WILL ATTEND THE ORACLE NETSUITE CONFERENCE, notifiCRM INTEGRATION WILL BE COMPLETED AT THAT TIME AND THERE WILL BE A BIG ANNOUNCEMENT
https://www.youtube.com/watch?v=SRv-XEqI-Qo&t=26s
nFUSZ HAS RECENTLY CLEANED ALL DEBT FROM ITS BALANCE SHEET.

ALL TOP nFUSZ EXECUTIVES ARE BEING COMPENSATED WITH STOCK AS NOTED IN RECENT SEC FORM 4s
https://www.otcmarkets.com/stock/FUSZ/disclosure
FUSZ SHARES CLOSED FRIDAY AT $1.54 GIVING IT A MARKET CAP OVER $222M, HOW MUCH MORE EXPENSIVE WOULD ORACLE LIKE nFUSZ TO BECOME THEY ACT OR PERHAPS SOME OTHER BIG TECH SUITOR? 

SURE LOOKS LIKE nFUSZ HAS BEEN PREPPED FOR A BUYOUT.

LET THE BUILDING WAR FOR THIS GAME CHANGING, INDUSTRY DISRUPTING SOFTWARE TECHNOLOGY BEGIN.

MORE DD: https://investorshangout.com/post/view?id=4972788

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Legal Action Announced for Investors of Synopsys, Inc.

Updated Category News Views 132

Class Action Overview for Synopsys, Inc. Investors The Portnoy Law Firm has stepped forward to support investors of Synopsys, Inc., a prominent player in the software industry known for its electronic design automation solutions. Investors who purchased securities between December 4, 2024, and September 9, 2025, are being invited to participate in a class action lawsuit....

Continue Reading
Welcome New Members to the SIG Shooter Affiliate Program

Updated Category News Views 93

Welcoming New Affiliates to the SIG Shooter Program SIG SAUER is thrilled to announce the addition of Tre'Von Barber, Kaylee Lane, and Todd Sindelar to the SIG Shooter Affiliate Program. This exciting initiative, slated to begin soon, aims to bolster their representation at significant competitive shooting events across the nation. Introducing Tre'Von Barber Tre'Von...

Continue Reading
MassageLuXe Expands DFW Presence with New Spa Locations

Updated Category News Views 312

MassageLuXe Expands Its Presence in Dallas-Fort Worth Region MassageLuXe, a renowned luxury spa franchise, is set to make waves in the Dallas-Fort Worth region. With plans to launch more than 20 new locations, this strategic growth initiative aims to tap into the increasing demand for wellness and self-care services across the area. A New Era of Self-Care In recent years,...

Continue Reading
Exciting Growth Ahead for the Ceramic Fiber Market

Updated Category News Views 150

The ceramic fiber market was gearing up for a substantial leap, eyeing a worth of $3.5 billion by 2029, with a robust CAGR of 8.6% from 2024 onward. Traders were already buzzing about the heat resistance and low thermal conductivity that made these fibers prime players across several industries. Drivers of Ceramic Fiber Market Growth: Energy Efficiency & Sustainability...

Continue Reading
Promising Insights on HOPE Technology for Liver Health

Updated Category News Views 138

Innovative HOPE Technology in Liver Transplantation Recent research from Italy has been diving into Hypothermic Oxygenated Perfusion (HOPE), showcasing its safety in liver transplants and its potential to improve patient outcomes. These studies were presented during a major international congress, marking a significant milestone in the field. Researchers are excited about...

Continue Reading